Media

In a new white paper issued today, BIO updates the results of a study of the greenhouse gas emissions resulting from EPA's proposal to reduce biofuel use...
BIO is pleased to announce the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology to be presented to an outstanding...

Press Releases

Feb 4 2002
Washington, D.C. (February 4, 2002) – The FDA approved 16 new biotechnology-based medicines and vaccines in 2001, as well as eight new indications for...
Jan 30 2002
WASHINGTON, DC – (January 30, 2002) – Advance media registration for the 16th annual BIO 2002 International Convention and Exhibition is now available. The...
Jan 18 2002
WASHINGTON, D.C. - (January 18, 2002) - Biotechnology Industry Organization Vice President for Bioethics Michael Werner released the following statement on the...
Dec 19 2001
Washington, D.C. (December 19, 2001) – The Centers for Medicare and Medicaid Services Wednesday postponed by at least three months implementation of a...
Dec 13 2001
WASHINGTON, D.C. - (December 13, 2001) - Sharon L. Cohen, vice president of government relations for the Biotechnology Industry Organization (BIO), released a...
Dec 12 2001
Washington, D.C. (December 12, 2001) - The Biotechnology Industry Organization (BIO) has selected Philadelphia as the site of the BIO 2005 International...
Dec 12 2001
Washington, D.C. (December 12, 2001) - The Biotechnology Industry Organization (BIO) has selected Chicago, Illinois, as the site of the BIO 2006 International...
Dec 6 2001
WASHINGTON, D.C. (December 6, 2001) – The 16th annual International Biotechnology Convention and Exhibition, BIO 2002, will be held June 9-12 at the...
Dec 4 2001
Washington, D.C. (December 4, 2002) - The Biotechnology Industry Organization (BIO) will host the fourth annual CEO & Investor Conference, “Investing...


Biotechnology News

October 30, 2014

DOYLESTOWN, Pa.--(BUSINESS WIRE)--Marcum LLP and Philadelphia SmartCEO recognized the area’s top leaders in innovation at the 2014 Marcum Innovator of the Year Awards,...

October 30, 2014

BOSTON--(BUSINESS WIRE)--The Joslin Institute for Technology Translation (JITT) announces that three Johnson & Johnson Diabetes Solutions Companies have joined JITT as...

October 30, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter presented the results of a Phase 2/3 study of its investigational 20 percent concentration subcutaneous immunoglobulin treatment...

October 30, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Phase 2 Objective Response Rate&Survival Data for Opdivo(nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung...

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and...